Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects
Clinical trial NCT05468060 · COMPLETED
Trial details
- NCT number
- NCT05468060
- Sponsor
- Zhejiang Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2020-12-12
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.